Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Blood|April 15, 2024
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic featuresMarta Sureda-Gómez, Ingram Iaccarino, Anna De Bolòs, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Blood Advances|October 28, 2022
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphomaJakoba J Eertink, Gerben J C Zwezerijnen, Sanne E Wiegers, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Leukemia & Lymphoma|August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYCUlrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2021
Microstratigraphic preservation of ancient faunal and hominin DNA in Pleistocene cave sedimentsDiyendo Massilani, Mike W Morley, Susan M Mentzer, et al.
Nature Medicine|May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphomaBjörn Lamprecht, Korden Walter, Stephan Kreher, et al.
Genes, Chromosomes & Cancer|July 16, 2015
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphomaRabea Wagener, Sietse M Aukema, Matthias Schlesner, et al.
Plos One|July 9, 2011
Epigenetic activation of SOX11 in lymphoid neoplasms by histone modificationsMaria Carmela Vegliante, Cristina Royo, Jara Palomero, et al.
Blood|October 28, 2020
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1Sarah Reinke, Paul J Bröckelmann, Ingram Iaccarino, et al.
Pageof 13